Search research articles
Contact Us
Filters
Showing results (351-360 of 366) with videos related to
Page
of 37
Sort By:
International Journal of Cancer
|
December 10, 2016
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation
Sebastian M Dieter, Klara M Giessler, Mark Kriegsmann, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
December 13, 2023
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation
Max Bittrich, Katharina Kriegsmann, Carola Tietze-Stolley, et al.
Journal of Cancer Research and Clinical Oncology
|
November 27, 2019
DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics
Felix K F Kommoss, Damian Stichel, Daniel Schrimpf, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
October 30, 2023
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study
Katharina Kriegsmann, Max Bittrich, Sandra Sauer, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 13, 2024
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project
Ernst-Jan M Speel, Urania Dafni, Erik Thunnissen, et al.
Trials
|
October 7, 2020
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial
Maike Janssen, Ulrike Schäkel, Carine Djuka Fokou, et al.
Ebiomedicine
|
January 5, 2023
Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
M Alvaro Berbís, David S McClintock, Andrey Bychkov, et al.
The Lancet. Haematology
|
November 3, 2022
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
Hartmut Goldschmidt, Elias K Mai, Uta Bertsch, et al.
Journal of Pathology Informatics
|
May 21, 2026
How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology
Joshua Pantanowitz, Christopher D Manko, John Majewski, et al.
Leukemia
|
June 3, 2024
CD8<sup>+</sup> CD28<sup>-</sup> regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study
Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 366) with videos related to
Sort By:
Page
of 37
International Journal of Cancer
|
December 10, 2016
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation
Sebastian M Dieter, Klara M Giessler, Mark Kriegsmann, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
December 13, 2023
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation
Max Bittrich, Katharina Kriegsmann, Carola Tietze-Stolley, et al.
Journal of Cancer Research and Clinical Oncology
|
November 27, 2019
DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics
Felix K F Kommoss, Damian Stichel, Daniel Schrimpf, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
October 30, 2023
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study
Katharina Kriegsmann, Max Bittrich, Sandra Sauer, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 13, 2024
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project
Ernst-Jan M Speel, Urania Dafni, Erik Thunnissen, et al.
Trials
|
October 7, 2020
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial
Maike Janssen, Ulrike Schäkel, Carine Djuka Fokou, et al.
Ebiomedicine
|
January 5, 2023
Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
M Alvaro Berbís, David S McClintock, Andrey Bychkov, et al.
The Lancet. Haematology
|
November 3, 2022
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
Hartmut Goldschmidt, Elias K Mai, Uta Bertsch, et al.
Journal of Pathology Informatics
|
May 21, 2026
How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology
Joshua Pantanowitz, Christopher D Manko, John Majewski, et al.
Leukemia
|
June 3, 2024
CD8<sup>+</sup> CD28<sup>-</sup> regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study
Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, et al.
Page
of 37